Ftse Mib
34.151,41
-0,27%
DAX
18.498,38
0,32%
S&P 500
5.187,67
0,00%
NASDAQ
16.302,76
-0,18%
Bitcoin
61.545,99
0,59%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Benitec Biopharma Limited (BNTC) Benitec Biopharma Limited (BNTC) Notizie

Benitec Biopharma Limited

BNTC
8,64
0,49 (6,01%)
09 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/3/202422:17EDGAR2Form 8-K - Current report
08/3/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/2/202415:06EDGAR2Form DEL AM - Delaying amendment
23/2/202422:09EDGAR2Form S-3 - Registration statement under Securities Act of..
13/2/202414:15EDGAR2Form 8-K - Current report
13/2/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/12/202322:15EDGAR2Form 8-K - Current report
30/11/202313:31EDGAR2Form 8-K - Current report
17/11/202314:00GLOBEBenitec Biopharma to Participate in a Fireside Chat at the..
13/11/202314:03EDGAR2Form 8-K - Current report
13/11/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:00GLOBEBenitec Biopharma Releases First Quarter 2024 Financial..
20/10/202322:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/10/202312:04EDGAR2Form DEF 14A - Other definitive proxy statements
16/10/202323:29EDGAR2Form 8-K - Current report
28/9/202323:19EDGAR2Form 8-K - Current report
21/9/202314:05EDGAR2Form 8-K - Current report
21/9/202314:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/9/202314:00GLOBEBenitec Biopharma Releases Full Year 2023 Financial Results..
18/9/202323:26EDGAR2Form 8-K - Current report
14/8/202323:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:01EDGAR2Form 8-K - Current report
11/8/202319:00GLOBEBenitec Biopharma Inc. Announces Closing of $30 Million..
10/8/202322:42EDGAR2Form 8-K - Current report
10/8/202322:06EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
09/8/202304:30GLOBEBenitec Biopharma Inc. Announces Pricing of $30 Million..
07/8/202314:11EDGAR2Form S-1/A - General form for registration of securities..
03/8/202314:27EDGAR2Form S-1/A - General form for registration of securities..
31/7/202314:34EDGAR2Form S-1/A - General form for registration of securities..
25/7/202320:08EDGAR2Form 8-K - Current report
25/7/202319:00GLOBEBenitec Biopharma Announces 1-for-17 Reverse Stock Split..
07/7/202322:52EDGAR2Form S-1 - General form for registration of securities under..
26/6/202314:00GLOBEBenitec Biopharma Receives FDA Clearance of the IND for..
15/5/202314:00GLOBEBenitec Biopharma Releases Third Quarter 2023 Financial..
Apertura: 8,03 Min: 8,03 Max: 8,7615
Chiusura: 8,15

La tua Cronologia

NASDAQ
BNTC
Benitec Biopharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network